NCT00212264

Brief Summary

The primary purpose of this study is to test the effectiveness, impact on quality of life, and durability of non-surgical therapies for incontinence persisting at least one year after surgery. The study is a a prospective, controlled, randomized trial comparing an 8-week, multi-component behavioral training program (pelvic floor muscle exercises, self-monitoring with bladder diaries, regular office visits, bladder control techniques, and fluid management) to the same program with the addition of biofeedback and pelvic muscle electrical stimulation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
208

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2003

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2003

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

September 13, 2005

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 21, 2005

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2008

Completed
2.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2011

Completed
4.7 years until next milestone

Results Posted

Study results publicly available

April 11, 2016

Completed
Last Updated

April 11, 2016

Status Verified

March 1, 2016

Enrollment Period

5.1 years

First QC Date

September 13, 2005

Results QC Date

October 7, 2014

Last Update Submit

March 21, 2016

Conditions

Keywords

urinary incontinencetherapyprostatectomyprostate cancer

Outcome Measures

Primary Outcomes (2)

  • Percent Change in Incontinence Episodes on Bladder Diary

    \[(Baseline incontinence episodes minus 2-month incontinence episodes)/baseline incontinence episodes\] x 100%

    2 months

  • Percent Change in Incontinence Episodes Per Week on Bladder Diary

    \[(Baseline incontinence episodes minus 12-month incontinence episodes)/baseline incontinence episodes\] x 100%

    1 year

Study Arms (3)

Behavioral Therapy

EXPERIMENTAL

Behavioral Therapy (Pelvic floor muscle training, bladder control strategies)

Behavioral: Behavioral Therapy

Behavioral Therapy Plus Technologies

EXPERIMENTAL

Behavioral therapy plus technologies (home pelvic floor electrical stimulation and biofeedback)

Behavioral: Behavioral TherapyDevice: Pelvic Floor Electrical StimulationBehavioral: Biofeedback

Placebo Comparator

PLACEBO COMPARATOR

No treatment control

Other: No Treatment

Interventions

Pelvic Floor Muscle Exercises and Bladder control strategies

Behavioral TherapyBehavioral Therapy Plus Technologies

Pelvic Floor Electrical Stimulation daily for 8 weeks

Behavioral Therapy Plus Technologies
BiofeedbackBEHAVIORAL

Pelvic Floor Muscle training via biofeedback

Behavioral Therapy Plus Technologies

No treatment

Placebo Comparator

Eligibility Criteria

Sexmale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Involuntary loss of urine that started immediately after radical prostatectomy and has persisted for at least one year.
  • One-week bladder diary with interpretable data and at least two incontinence episodes

You may not qualify if:

  • Any unstable medical condition, particularly decompensated congestive heart failure, history of malignant arrhythmias, or unstable angina
  • Cardiac pacemaker or implanted cardiac defibrillator
  • Current use of anticholinergic agents for detrusor instability
  • Folstein's Mini-Mental State Exam score below 24 (impaired mental status)
  • One-week bladder diary with continual leakage - defined as always being damp or wet or unable to quantitate individual accidents.
  • Poorly controlled diabetes, defined as (glycosylated hemoglobin \> 9 within last 3 months).
  • Hematuria on microscopic examination. Enrollment will be permitted after urologic evaluation.
  • Urodynamic evaluation: Post-void residual volume greater than 200 mL

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alabama at Birmingham

Birmingham, Alabama, 35294, United States

Location

Related Publications (2)

  • Goode PS, Burgio KL, Johnson TM 2nd, Clay OJ, Roth DL, Markland AD, Burkhardt JH, Issa MM, Lloyd LK. Behavioral therapy with or without biofeedback and pelvic floor electrical stimulation for persistent postprostatectomy incontinence: a randomized controlled trial. JAMA. 2011 Jan 12;305(2):151-9. doi: 10.1001/jama.2010.1972.

  • Johnson EE, Mamoulakis C, Stoniute A, Omar MI, Sinha S. Conservative interventions for managing urinary incontinence after prostate surgery. Cochrane Database Syst Rev. 2023 Apr 18;4(4):CD014799. doi: 10.1002/14651858.CD014799.pub2.

MeSH Terms

Conditions

Urinary IncontinenceProstatic Neoplasms

Interventions

Behavior TherapyBiofeedback, Psychology

Condition Hierarchy (Ancestors)

Urination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsGenital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsGenital Diseases, MaleGenital DiseasesProstatic Diseases

Intervention Hierarchy (Ancestors)

PsychotherapyBehavioral Disciplines and ActivitiesMind-Body TherapiesComplementary TherapiesTherapeuticsFeedback, Psychological

Results Point of Contact

Title
Patricia S Goode, MD
Organization
University of Alabama at Birmingham

Study Officials

  • Patricia S Goode, MD

    University of Alabama at Birmingham

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
NIH
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 13, 2005

First Posted

September 21, 2005

Study Start

August 1, 2003

Primary Completion

September 1, 2008

Study Completion

August 1, 2011

Last Updated

April 11, 2016

Results First Posted

April 11, 2016

Record last verified: 2016-03

Locations